Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 668 of 1,261

  1. US 9481662

    Seriniquinones, melanoma-specific anticancer agents

    The Regents of the University of California · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  2. US 9480754

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  3. US 9481654

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  4. US 9480669

    Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion

    The Regents of the University of California · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  5. US 9480770

    Methods for preparation of medical dressing containing antimicrobial agent

    Covidien LP · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  6. US 9481692

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  7. US 9480675

    Method for increasing muscle growth by blocking sirtuin activity

    The Regents of the University of California · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  8. US 9474793

    Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  9. US 9474743

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  10. US 9474795

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  11. US 9475795

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  12. US 9475832

    Phosphonates with reduced toxicity for treatment of viral infections

    The Regents of the University of California · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  13. US 9475869

    Human antibodies to fel d1 and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  14. US 9475816

    Substituted-1,4-dihydropyrazolo[4,3-b]indoles

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  15. US 9475781

    Fumarate analogs and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  16. US 9474796

    Crimean-Congo hemorrhagic fever virus vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  17. US 9474830

    PEGylated fibrinogen precursor molecule

    REGENTIS BIOMATERIALS LTD. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  18. US 9474716

    SiRNA phospholipid conjugate

    Northwestern University · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  19. US 9474804

    Poly(vinyl ester) polymers for in vivo nucleic acid delivery

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  20. US 9474797

    African swine fever virus georgia strain adapted to efficiently grow in the vero cell line

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  21. US 9474787

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  22. US 9474768

    Lubricant formulations

    Reoxcyn Discoveries Group, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  23. US 9474779

    Therapeutically active compositions and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  24. US 9474784

    Therapeutic applications of SMAD7

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.